Resources

Showing 72 Results

Value-Based Performance Arrangements for Chronic Conditions: An Economic Simulation of Medicaid Drug Rebate Program Reforms

Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States

Study shows the impact of a more holistic approach to assessing value and how it can help address gaps within conventional value assessment.

Characterizing health plan evidence review practices: how often, how different, and how comprehensive?

All health care decisions should be evidence-based. Until now, it has been relatively unclear what goes into health plan evidence reviews. How frequently do health plans update their specialty drug…

How Reforms Can Enable Payment Innovation That Drives Value

This NPC study models the effects of recent and proposed payment reforms related to CMS' best price reporting rules and sheds light on which approaches may encourage the adoption of value-based…

Study on Medicare Best Price and Payment Reform

Paying for Cell and Gene Therapies Enabled by Medicaid Best Price Reforms

Value Assessment’s ‘Leaky Bucket’ Problem

In Health Affairs Forefront, NPC outlines the challenges in assessing the value of new treatments and proposes a framework and recommendations to ensure patient access to new therapies and continued…

Making Our Health Care System More Supportive and Inclusive for Caregivers

NPC President and CEO John M. O'Brien writes about how we can better incorporate the needs of caregivers into our health care system and provide them the support they deserve.

The Impact of COVID-19 on Real-World Health Data and Research

This white paper provides key health care stakeholders, including clinicians, researchers, payers and regulators, with a broad view of how the COVID-19 pandemic may have impacted real-world data (RWD…

What’s In Your RWE Evaluation Toolbox?

Real-world evidence (RWE) – information collected from everyday health care experiences – is growing in availability, and many health care decision-makers are interested in understanding and using…

Online Tools to Synthesize Real-World Evidence of Comparative Effectiveness Research to Enhance Formulary Decision Making

This JMCP study describes and compares the features and characteristics of five tools to evaluate real-world evidence studies and adds clarity on what the tools provide.

NPC’s Research Informs Policy Conversations

NPC's work was broadly featured in the Journal of Managed Care & Specialty Pharmacy’s 12-part 25th anniversary series featuring “topics of significance” in managed care.

NPC Patient-Reported Measures Research Featured at AMCP Nexus 2020

A panel at the Academy of Managed Care Pharmacy Nexus 2020 explored the tension between patient-reported measures funding and innovation and highlighted published research by NPC and Discern Health.

NPC Comments on PCORI's Proposed Principles for the Consideration of the Full Range of Outcomes Data

NPC offered public feedback to PCORI on its new mandate to consider the full range of patient-centered outcomes in its research.

Are ACOs Optimizing Medication Use?

An article in JMCP revisits a 2014 NPC study that surveyed Accountable Care Organizations (ACOs) readiness to optimize medication use. The Reflection article summarizes changes to the ACO policy…

Infographic of healthcare related icons and illustrations

E.V.I.dently October 2020

This month marks the last time you’ll see E.V.I.dently® in its current format and layout. That’s because we’re working on some exciting changes to our e-newsletters and website, with an eye toward…

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How Recommendations and a Roadmap from the Real-World Evidence Transparency Initiative

A position paper by the RWE Transparency Initiative describes a plan for improving the transparency of the research process and making registration of real-world evidence study methods easier and…

Filter by: